Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 9.09 percent. This is a 76.74 percent increase over losses of $(0.43) per share from the same period last year.